Table 2 Treatment details and outcome
Case | Gabexate mesilate/nafamostat mesilate | FFP | RCC | R. tigrinus antivenom | Time interval between getting yamakagashi bites and antivenom administration (h) | Adverse effects related with antivenom | Severe adverse effects | ICU days | Hospital days | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|
1 | No | No | No | No | 2 | 2 | Survival | |||
2 | No | Yes | Yes | No | 6 | 6 | Dead | |||
3 | No | No | No | Yes | 5.5 | No | No | 2 | 4 | Survival |
4 | Yes | No | No | Yes | 24 | No | No | 0 | 6 | Survival |
5 | No | No | No | Yes | 28 | No | No | 0 | 6 | Survival |
6 | No | No | No | Yes | 35 | No | No | 0 | 7 | Survival |
7 | No | No | No | Yes | 35 | No | No | 2 | 4 | Survival |
8 | Yes | Yes | Yes | Yes | 60 | No | No | 0 | 14 | Survival |
9 | Yes | Yes | No | Yes | 60 | No | No | 0 | 6 | Survival |
Summary | Yes, 33% | Yes, 33% | Yes, 22% | Yes, 78% | 35 (5.5–60) | Yes, 0% | Yes, 0% | 0 (0–6) | 6 (2–14) | Survival, 89% |